ft 01 oct 93 technolog mission divid rule paul abraham explain motiv behind glaxo r amp shake glaxo europ largest drug compani also one world innov standard research develop lab recent decad develop seri remark success compound includ zantac world best sell medicin last financi year gener revenu pound 2 1bn recent compani launch seri ground break molecul imigran migrain drug zofran anti nausea treatment given glaxo r amp record last week announc reorganis top r amp organis scrutinis group tri emul success reorganis involv split posit r amp director appoint sir mark richmond chairman scienc engin research council director research goran ando swedish execut recent appoint r amp director becom director group develop product strategi richard syke glaxo chief execut elev posit r amp director march insist chang mere result promot mission creat discov develop manufactur sell prescript medicin 100 per cent commit prescript drug busi counter medicin distil water ice cream syke insist glaxo success prescript drug must develop treatment safe effect offer ad valu littl point develop medicin littl ad valu explain glaxo plan move untap market yet satisfi futur success compani 10 20 year time depend upon develop innov medicin say syke innov drug emerg scienc base undergo enorm chang accord syke wit paradigm shift biolog scienc first increasingli understand genet basi diseas everi week 3 000 gene identifi second know microbiolog process life death cell understand physiolog diseas scientist abl identifi target site drug easili offer potenti develop effect agent treat chronic ill well treat moment explain har new technolog access realli critic futur compani need good peopl say syke lot help outsid 1 500 peopl involv research intern enough rapid expans knowledg base advanc happen academia biotechnolog industri critic strong tie futur drug come pharmaceut industri come research boutiqu work import target glaxo formal link eight 10 biotechnolog group compani also give money 70 per cent uk univers past tradit r amp organis need chang structur har implement new technolog increasingli difficult one man overse research develop glaxo decid split function explain sir mark syke say except scientif skill experi molecular genet edinburgh univers microbi biolog bristol univers also develop organis abil run serc vice chancellor manchest univers syke believ period serc place cut edg scienc intern basi say sir mark contact scientif commun help recruit top talent glaxo new pound 700m research complex stevenag due open 1995 compani hire number addit scientist greenford ware oper transfer stevenag syke say anoth reason split research develop huge differ object research see go lot differ avenu explor develop know exactli go seri regulatori hurdl way negoti conceptu differ need differ sort peopl run two oper develop process remain highli critic insist syke 75 per cent r amp expenditur goe develop 25 per cent research glaxo one best develop record industri set gold standard time taken negoti regulatori hurdl new drug safeti efficaci valu data provid platform market close link product strategi develop process form rational ando appoint say syke ando respons pre clinic develop clinic develop relationship regul product strategi inform technolog manag servic licens also liais power oper compani glaxo explain develop requir nation market syke believ reorganis help ensur group pharmaceut r amp invest largest world set pound 850m 1994 well spent